When using a low dose (5 μM) ofberberine, the AMPK/HIF-1α signaling pathway is inhibited and the expression of P-gp decreases, thereby increasing the sensitivity of breast cancer cells to chemotherapy drugs. This evidence concerns the gene HIF1A and breast carcinoma.